We are Sorry, This Page doesn't Exist
FDA approves Bristol-Myers combo for metastatic non-small cell lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers Squibb stock falls 5% on lung cancer drug study results
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Bristol-Myers Squibb stock falls on lung cancer drug study result
Bristol-Myers Squ.....»»
Bristol-Myers wins FDA approval for Opdivo as treatment for small cell lung cancer
Bristol-Myers Squibb Co. said Friday the U.S. Food and Drug Admi.....»»
Bristol-Myers" Opdivo Gets FDA Nod for Small Cell Lung Cancer
Bristol-Myers' (BMY) blockbuster immuno-oncology drug Opdivo gets the FDA approval for small cell lung cance.....»»
Bristol-Myers Squibb shares decline on failed lung-cancer drug study
Bristol-Myers Squibb Co. shares declined in the extended session Monday after the drug maker said a lung-cancer treatment.....»»
Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug
Bristol-Myers Squibb Co (NYSE.....»»
Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA approves Bristol-Myers" Opdivo for initial treatment of gastric cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) read more.....»»
China suspends Bristol-Myers" cancer drug sales over findings at U.S. plant
Sales of Bristol-Myers Squibb Co's cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing plant in the United States......»»
China suspends Bristol-Myers" cancer drug over findings at U.S. plant
China has suspended sale, import and use of Bristol-Myers Squibb Co's cancer drug, Abraxane, the U.S. drugmaker's China marketing partner said on Wednesday......»»
Bristol-Myers: Japan"s MHLW approves Opdivo for treatment of esophageal cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers shares surge almost 5% premarket after positive results in lung-cancer trial
Bristol-Myers Squibb Co. shares rose almost 5% in premarket Tuesday, after the company reported positive result.....»»
Bristol-Myers cancer drug Opdivo fails to meet a primary endpoint in phase 3 trial
Bristol-Myers Squibb Co. said a phase 3 trial (CheckMate-548) evaluating its blockbuster cancer drug Opdivo as an addition to the current standard of care versus the st.....»»
Bristol-Myers" Opdivo Gets Priority Review for Lung Cancer
The FDA accepts Bristol-Myers Squibb's (BMY) supplemental Biologics License Application and grants priority review for the label expansion of Opdi.....»»
Bristol-Myers downgraded on lung cancer data disappointment at Morgan Stanley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck Cements Lead in Lung Cancer as Bristol-Myers Fizzles
Merck & Co. might have just shut the door on rival Bristol-Myers Squibb Co. as investors weigh new data that could reshape the treatment of lung cancer, by far the deadliest form of cancer in the U.S......»»
Merck shares surge anew on lung cancer advance, while Bristol-Myers stock plummets
The pairing of Keytruda and chemotherapy reduced risk of death for patients with advanced lung cancer by half, a significant improvement......»»
Bristol-Myers shares drop 5% on late-stage lung cancer results
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»